Search clinical trials for: BAY1834845

Total 6 results

Bayer

Completed

First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

Pelvic Inflammatory Disease

Germany
Bayer

Completed

Study of BAY1834942 in Patients With Solid Tumors

Advanced CEACAM6-expressing Solid Tumors

United States, Singapore, Canada
Bayer

Completed

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis (Damask)

Atopic Dermatitis

France, Czechia, Italy, Poland, United States, Germany, United Kingdom
Bayer

Completed

A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants

Immune Mediated Inflammatory Diseases

Netherlands
Bayer

Completed

A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis

Psoriasis | Healthy Volunteers

Germany
Bayer

Completed

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

Inflammation

Netherlands

3

Subscribe